Skip to main content

Table 2 Cardiac parameters calculated from Magnetic Resonance exams performed through the study

From: Delayed administration of allogeneic cardiac stem cell therapy for acute myocardial infarction could ameliorate adverse remodeling: experimental study in swine

 

CON group

D7 group

D0 group

 

Baseline (preinfarction)

Day 0 preinjection

1 week

10 weeks

Baseline (preinfarction)

Day 0 preinjection

1 week

10 weeks

Baseline (preinfarction)

1 week

10 weeks

Weight (kg)

32.5 ± 1.87

33.8 ± 1.33

33.0 ± 1.67

39.17 ± 2.71

30.67 ± 1.97

31.00 ± 3.80

30.33 ± 2.73

41.33 ± 5.01

31.60 ± 2.07

34.60 ± 1.67

42.60 ± 4.98

EF (%)

51.57 ± 7.48

38.22 ± 10.4

41.03 ± 5.66

41.70 ± 10.88

51.08 ± 7.68

41.07 ± 7.50

42.17 ± 5.70

45.93 ± 6.15

54.24 ± 8.63

36.58 ± 8.97

42.58 ± 8.80

EDVi (mL/m2)

82.61 ± 18.36

106.24 ± 10.96

110.16 ± 11.49

121.70 ± 26.09*

79.18 ± 13.20

97.86 ± 13.00

106.57 ± 8.42

98.71 ± 8.30*

79.95 ± 7.59

101.65 ± 22.02

106.04 ± 7.26

ESVi (mL/m2)

39.97 ± 9.47

66.1 ± 15.74

65.09 ± 10.39

72.72 ± 27.18

38.92 ± 9.65

57.60 ± 9.85

61.64 ± 8.00

53.45 ± 8.01

36.94 ± 9.58

65.28 ± 19.55

61.18 ± 12.08

% Infarct

n/a

17.20 ± 5.54

11.33 ± 2.94

7.50 ± 2.07

n/a

16.33 ± 3.61

13.33 ± 4.88

10.00 ± 4.29

n/a

17.00 ± 3.46

9.40 ± 2.79

Infarct mass (g)

n/a

13.28 ± 4.96

7.46 ± 1.92

5.25 ± 1.32

n/a

10.49 ± 2.65

7.95 ± 2.36

6.20 ± 2.45

n/a

12.16 ± 3.88

7.03 ± 2.29

  1. Data presented as mean ± standard deviation. EF: Ejection fraction. EDVi: End diastolic volume indexed to body surface area. ESVi: End systolic volume indexed to body surface area. n/a: Not applicable. * P < 0.05 (Mann Whitney U test. Intergroup comparisons at each time point)